Aspirin in the primary prevention of cardiovascular disease in individuals with chronic kidney disease: a systematic review and meta-analysis

Back

EAPC Premium Access

Aspirin in the primary prevention of cardiovascular disease in individuals with chronic kidney disease: a systematic review and meta-analysis

Session: Young Investigators Award Primary Care and Risk Factor Management

Topic: Antiplatelet Drugs

Speaker: Doctor S. Pallikadavath (Leicester, GB)

Event: ESC Preventive Cardiology 2021

Congress Presentation

Add to my library

About the speaker

Doctor Susil Pallikadavath

NIHR Biomedical Research Unit in Cardiovascular Disease, Leicester (United Kingdom of Great Britain & Northern Ireland)

0 follower

5 more presentations in this session

Impact of obesity on the clinical outcomes of patients undergoing pacemaker insertion during hospitalization: An analysis of the United States National Inpatient Sample

Speaker: Doctor M. Almani (Chicago, US)

Cardiovascular outcomes of ferric carboxymaltose supplementation for the management of iron-deficient acute and chronic heart failure- a meta analysis

Speaker: Ms A. Abdul Razzack (Vijayawada, IN)

Ttrimetyllysine and risk of new-onset atrial fibrillation in two large norwegian cohorts

Speaker: Doctor M. Svenningsson (Bergen, NO)

Province-specific recalibration of CVD risk models using population-specific routine data for Chinese people is important

Speaker: Ms D. Zhang (Cambridge, GB)

Galectin-3 is inversely associated with cardiorespiratory fitness in the general population

Speaker: Miss M. Haid (Greifswald, DE)

Access the full session

Young Investigators Award Primary Care and Risk Factor Management

Speakers: Doctor S. Pallikadavath, Doctor M. Almani, Ms A. Abdul Razzack, Doctor M. Svenningsson, Ms D. Zhang...

Access

Video

About the event

ESC Preventive Cardiology 2021

15 April - 17 April 2021

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources